12 results for author:"Vanden Bos T." in Literature citations
Results Customize
› Repeat search in UniProtKB (15)
| Cutting edge: interleukin 17 signals through a heteromeric receptor complex. Toy D., Kugler D., Wolfson M., Vanden Bos T., Gurgel J., Derry J., Tocker J., Peschon J. J. Immunol. 177:36-39(2006) · Mapped (14) |
| Identification of potent human anti-IL-1RI antagonist antibodies. Fredericks Z.L., Forte C., Capuano I.V., Zhou H., Vanden Bos T., Carter P. Protein Eng. Des. Sel. 17:95-106(2004) · UniProtKB (1) |
| Molecular characterization of the human interleukin (Il)-17 receptor. Yao Z., Spriggs M.K., Derry J.M.J., Strockbine L., Park L.S., Vanden Bos T., Zappone J., Painter S.L., Armitage R.J. Cytokine 9:794-800(1997) · UniProtKB (1) |
| LERK-7: a ligand of the Eph-related kinases is developmentally regulated in the brain. Kozlosky C.J., Vanden Bos T., Park L.S., Cerretti D.P., Carpenter M.K. Cytokine 9:540-549(1997) · UniProtKB (1) |
| Isolation of LERK-5: a ligand of the eph-related receptor tyrosine kinases. Cerretti D.P., Vanden Bos T., Nelson N., Kozlosky C.J., Reddy P., Maraskovsky E., Park L.S., Lyman S.D., Copeland N.G., Gilbert D.J. et al. Mol. Immunol. 32:1197-1205(1995) · UniProtKB (2) · Mapped (18) |
| Molecular characterization of receptors for human interleukin-8, GRO/melanoma growth-stimulatory activity and neutrophil activating peptide-2. Cerretti D.P., Kozlosky C.J., Vanden Bos T., Nelson N., Gearing D.P., Beckmann M.P. Mol. Immunol. 30:359-367(1993) · UniProtKB (2) |
| Molecular characterization of a family of ligands for eph-related tyrosine kinase receptors. Beckmann M.P., Cerretti D.P., Baum P., Vanden Bos T., James L., Farrah T., Kozlosky C., Hollingsworth T., Shilling H., Maraskovsky E. et al. |
| LERK-2, a binding protein for the receptor-tyrosine kinase ELK, is evolutionarily conserved and expressed in a developmentally regulated pattern. Fletcher F.A., Carpenter M., Shilling H., Baum P., Ziegler S., Gimpel S., Hollingsworth T., Vanden Bos T., Davison B.L., Lyman S.D. et al. |
| Ligands for the receptor tyrosine kinases hek and elk: isolation of cDNAs encoding a family of proteins. Kozlosky C.J., Maraskovsky E., McGrew J.T., Vanden Bos T., Teepe M., Lyman S.D., Srinivasan S., Fletcher F.A., Gayle R.B. III, Cerretti D.P. et al. Oncogene 10:299-306(1995) · UniProtKB (3) |
| Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Lyman S.D., James L., Vanden Bos T., Devries P., Brasel K., Gliniak B., Hollingsworth L.T., Picha K.S., McKenna H.J., Splett R.R. et al. |
| Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. Gearing D.P., Thut C.J., Vanden Bos T., Gimpel S.D., Delaney P.B., King J., Price V., Cosman D., Beckmann M.P. |
| Molecular characterization of the interleukin-8 receptor. Beckmann M.P., Munger W.E., Kozlosky C., Vanden Bos T., Price V., Lyman S., Gerard N.P., Gerard C., Cerretti D.P. Biochem. Biophys. Res. Commun. 179:784-789(1991) · UniProtKB (1) |